菌血症相关乳酸杆菌的体外黏附及血小板聚集特性
In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli.
作者信息
Kirjavainen P V, Tuomola E M, Crittenden R G, Ouwehand A C, Harty D W, Morris L F, Rautelin H, Playne M J, Donohue D C, Salminen S J
机构信息
Department of Biochemistry and Food Chemistry, University of Turku, Turku, Finland.
出版信息
Infect Immun. 1999 May;67(5):2653-5. doi: 10.1128/IAI.67.5.2653-2655.1999.
Abstract
Eight bacteremia-associated Lactobacillus strains were evaluated in vitro for the ability to adhere to human intestinal mucosa and to aggregate platelets. Adherence varied significantly among the strains, and platelet aggregation was induced by three strains. In conclusion, strong binding ability does not appear to be a prerequisite for the involvement of lactobacilli in bacteremia or to their ability to aggregate platelets.
摘要
对八株与菌血症相关的乳酸杆菌菌株进行了体外评估，以检测它们黏附于人类肠黏膜和凝集血小板的能力。各菌株间的黏附能力差异显著，有三株菌株可诱导血小板凝集。总之，对于乳酸杆菌参与菌血症或其凝集血小板的能力而言，强大的结合能力似乎并非必要条件。
相似文献
1
In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli.菌血症相关乳酸杆菌的体外黏附及血小板聚集特性
Infect Immun. 1999 May;67(5):2653-5. doi: 10.1128/IAI.67.5.2653-2655.1999.
2
Pathogenic potential of lactobacilli.乳酸杆菌的致病潜力。
Int J Food Microbiol. 1994 Dec;24(1-2):179-89. doi: 10.1016/0168-1605(94)90117-1.
3
Good adhesion properties of probiotics: a potential risk for bacteremia?益生菌良好的黏附特性：会是菌血症的一个潜在风险吗？
FEMS Immunol Med Microbiol. 2001 Jul;31(1):35-9. doi: 10.1111/j.1574-695X.2001.tb01583.x.
4
The aggregation of human platelets by Lactobacillus species.乳酸菌对人血小板的聚集作用。
J Gen Microbiol. 1993 Dec;139(12):2945-51. doi: 10.1099/00221287-139-12-2945.
5
Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates.乳酸杆菌菌株的安全性评估：粪便、血液及益生菌分离株中潜在风险因素的存在情况
Int J Food Microbiol. 2007 May 30;116(3):325-31. doi: 10.1016/j.ijfoodmicro.2007.02.002. Epub 2007 Mar 1.
6
In vitro adhesion specificity of indigenous Lactobacilli within the avian intestinal tract.禽类肠道内本土乳酸菌的体外黏附特异性
Appl Environ Microbiol. 2002 Oct;68(10):5155-9. doi: 10.1128/AEM.68.10.5155-5159.2002.
7
Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.乳酸菌对细菌病原体从黏液和Caco-2细胞表面的置换作用。
J Med Microbiol. 2003 Oct;52(Pt 10):925-930. doi: 10.1099/jmm.0.05009-0.
8
Lactobacillus strains belonging to Casei group display various adherence to enterocytes and mucus.属于干酪乳杆菌群的乳酸杆菌菌株对肠上皮细胞和黏液表现出不同的黏附性。
Acta Sci Pol Technol Aliment. 2015 Jul-Sep;14(3):247-255. doi: 10.17306/J.AFS.2015.3.26.
9
Lactobacillus crispatus and its nonaggregating mutant in human colonization trials.卷曲乳杆菌及其非聚集突变体在人体定植试验中的研究
J Dairy Sci. 2001 May;84(5):1001-10. doi: 10.3168/jds.S0022-0302(01)74559-6.
10
Lactobacillus casei NY1301 increases the adhesion of Lactobacillus gasseri NY0509 to human intestinal caco-2 cells.干酪乳杆菌NY1301增强了加氏乳杆菌NY0509对人肠道Caco-2细胞的黏附作用。
Biosci Biotechnol Biochem. 2001 Oct;65(10):2326-9. doi: 10.1271/bbb.65.2326.
引用本文的文献
1
Exploring the dark side of probiotics to pursue light: Intrinsic and extrinsic risks to be opportunistic pathogens.探索益生菌的阴暗面以追求光明：作为机会性病原体的内在和外在风险。
Curr Res Food Sci. 2025 Mar 31;10:101044. doi: 10.1016/j.crfs.2025.101044. eCollection 2025.
2
Members of the Genus Complex (LGC) as Opportunistic Pathogens: A Review.作为机会致病菌的类属复合体（LGC）成员综述
Microorganisms. 2019 May 10;7(5):126. doi: 10.3390/microorganisms7050126.
3
In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products.从发酵骆驼乳制品中分离出的天然免疫刺激剂乳酸菌发酵剂的体外和体内证据。
Sci Rep. 2018 Aug 22;8(1):12553. doi: 10.1038/s41598-018-31006-3.
4
Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.鼠李糖乳杆菌临床分离株的基因型和表型多样性、与GG菌株的比较及其被补体系统识别的情况
PLoS One. 2017 May 11;12(5):e0176739. doi: 10.1371/journal.pone.0176739. eCollection 2017.
5
ATCC 23271 Displays Inhibitory Activities against spp.美国典型培养物保藏中心23271对……显示出抑制活性
Front Microbiol. 2016 Oct 27;7:1722. doi: 10.3389/fmicb.2016.01722. eCollection 2016.
6
Lactobacillus rhamnosus GG inhibits the toxic effects of Staphylococcus aureus on epidermal keratinocytes.鼠李糖乳杆菌GG可抑制金黄色葡萄球菌对表皮角质形成细胞的毒性作用。
Appl Environ Microbiol. 2014 Sep;80(18):5773-81. doi: 10.1128/AEM.00861-14. Epub 2014 Jul 11.
7
Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and, at higher doses, produces lethality in a rat model.来自益生菌格氏乳杆菌的纯化细胞壁可激活全身炎症，并且在高剂量时会在大鼠模型中产生致死性。
Crit Care. 2014 Jul 2;18(4):R140. doi: 10.1186/cc13966.
8
Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper.儿科过敏中的益生菌临床应用（CUPPA）：世界过敏组织立场文件。
World Allergy Organ J. 2012 Nov;5(11):148-67. doi: 10.1097/WOX.0b013e3182784ee0.
9
Lactobacilli are prominent in the initial stages of polymicrobial infection of dental pulp.乳杆菌在牙髓多微生物感染的初始阶段很突出。
J Clin Microbiol. 2010 May;48(5):1732-40. doi: 10.1128/JCM.01912-09. Epub 2010 Mar 3.
10
Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria.人工细胞疗法：活菌治疗递送的新策略
J Biomed Biotechnol. 2005;2005(1):44-56. doi: 10.1155/JBB.2005.44.
本文引用的文献
1
Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics.人回肠造口术糖蛋白作为小肠黏液模型用于研究益生菌的黏附
Lett Appl Microbiol. 1999 Mar;28(3):159-63. doi: 10.1046/j.1365-2672.1999.00518.x.
2
Demonstration of safety of probiotics -- a review.益生菌安全性论证——综述
Int J Food Microbiol. 1998 Oct 20;44(1-2):93-106. doi: 10.1016/s0168-1605(98)00128-7.
3
The ability of probiotic bacteria to bind to human intestinal mucus.益生菌与人类肠道黏液结合的能力。
FEMS Microbiol Lett. 1998 Oct 15;167(2):185-9. doi: 10.1111/j.1574-6968.1998.tb13226.x.
4
Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures.部分益生菌和乳杆菌菌株对Caco-2细胞培养物的黏附作用。
Int J Food Microbiol. 1998 May 5;41(1):45-51. doi: 10.1016/s0168-1605(98)00033-6.
5
Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection.
Am J Clin Nutr. 1997 Aug;66(2):515S-520S. doi: 10.1093/ajcn/66.2.515S.
6
Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro.鼠李糖乳杆菌GG（ATCC 53103）与体外血小板聚集
Int J Food Microbiol. 1997 Jun 17;37(1):83-6. doi: 10.1016/s0168-1605(97)00049-4.
7
Common themes in microbial pathogenicity revisited.重新审视微生物致病性的常见主题。
Microbiol Mol Biol Rev. 1997 Jun;61(2):136-69. doi: 10.1128/mmbr.61.2.136-169.1997.
8
Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges.益生菌在稳定肠道黏膜屏障方面的临床应用：成功的菌株及未来挑战
Antonie Van Leeuwenhoek. 1996 Oct;70(2-4):347-58. doi: 10.1007/BF00395941.
9
Lactobacilli and bacteremia in southern Finland, 1989-1992.1989 - 1992年芬兰南部的乳酸杆菌与菌血症
Clin Infect Dis. 1996 Mar;22(3):564-6. doi: 10.1093/clinids/22.3.564.
10
The aggregation of human platelets by Lactobacillus species.乳酸菌对人血小板的聚集作用。
J Gen Microbiol. 1993 Dec;139(12):2945-51. doi: 10.1099/00221287-139-12-2945.
Zotero 插件